ABC | Volume 114, Nº1, Janeiro 2020

Minieditorial Gomes e Bocchi Qualidade de vida em insuficiência cardíaca Arq Bras Cardiol. 2020; 114(1):33-34 1. WorldHealthOrganization. (WHO). Depression and other commonmental disorders: global health estimates. Geneva;2017. 2. Ziegelstein RC, KimSY, Kao D, Fauerbach JA, Thombs BD, McCann U, et al. Can doctors and nurses recognize depression in patients hospitalizedwith an acutemyocardial infarction in the absence of formal screening? Psychosom Med. 2005;67(3):393-7. 3. Huffman JC, Smith FA, Blais MA, Beiser ME, Januzzi JL, Fricchione GL. Recognition and treatment of depression and anxiety in patients with acute myocardial infarction. Am J Cardiol. 2006;98(3):319-24. 4. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361-70. 5. AmericanPsychiatricAssociation.Diagnosticandstatisticalmanualofmental disorders (DSM-5®). Washington; 2013. 6. Figueiredo JHC, Oliveira GMMd, Pereira BB, Figueiredo AEB, Nascimento EM, GarciaMI, et al. Efeito Sinérgico da Gravidade da Doença, de Sintomas de Ansiedade e da Idade Avançada sobre aQualidade de Vida de Pacientes Ambulatoriais com Insuficiência Cardíaca. Arq Bras Cardiol. 2020; 114(1):25-32. 7. Rumsfeld JS, Havranek E, Masoudi FA, Peterson ED, Jones P, Tooley JF, et al. Depressive symptoms are the strongest predictors of short-term declines in health status in patients with heart failure. J Am Coll Cardiol. 2003;42(10):1811-7. 8. Gottlieb SS, Khatta M, Friedmann E, Einbinder L, Katzen S, Baker B, et al. The influence of age, gender, and race on the prevalence of depression in heart failure patients.J Am Coll Cardiol. 2004;43(9):1542-9. 9. Riba M, Wulsin L, Rubenfire M, Ravindranath D. Psychiatry and heart disease: themind, brain, and heart. Philadelphia: JohnWiley & Sons; 2012. 10. Rozanski A, Bavishi C, Kubzansky LD, Cohen R. Association of Optimism With Cardiovascular Events and All-Cause Mortality: A Systematic Review and Meta-analysis. JAMA Network Open. 2019;2(9):e1912200-e. 11. Rutledge T, Reis VA, Linke SE, Greenberg BH, Mills PJ. Depression in heart failure: a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J AmColl Cardiol. 2006;48(8):1527-37. 12. Strine TW, Mokdad AH, Dube SR, Balluz LS, Gonzalez O, Berry JT, et al. The association of depression and anxiety with obesity and unhealthy behaviors among community-dwelling US adults. Gen Hosp Psychiatry. 2008;30(2):127-37. 13. Whooley MA, de Jonge P, Vittinghoff E, Otte C, Moos R, Carney RM, et al. Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA. 2008;300(20):2379-88. 14. Roy SS, Foraker RE, Girton RA, Mansfield AJ. Posttraumatic stress disorder and incident heart failure among a community-based sample of US veterans. Am J Public Health. 2015;105(4):757-63. 15. Heo S, Doering LV, Widener J, Moser DK. Predictors and effect of physical symptom status on health-related quality of life in patients with heart failure. Am J Crit Care. 2008;17(2):124-32. 16. Friedmann E, Thomas SA, Liu F, Morton PG, Chapa D, Gottlieb SS, et al. Relationship of depression, anxiety, and social isolation to chronic heart failure outpatient mortality. AmHeart J. 2006;152(5):940. e1-e8. 17. Jiang W, Kuchibhatla M, Cuffe MS, Christopher EJ, Alexander JD, Clary GL, et al. Prognostic value of anxiety and depression in patients with chronic heart failure. Circulation. 2004;110(22):3452-6. 18. Freedland KE, Carney RM, Rich MW, Steinmeyer BC, Rubin EH. Cognitive behavior therapy for depression and self-care in heart failure patients: a randomized clinical trial. JAMA Intern Med. 2015;175(11):1773-82. 19. Gelenberg A, Freeman M, Markowitz J, Rosenbaum J, Thase M, Trivedi M, et al. Work Group onMajor Depressive Disorder. Practice Guideline for the Treatment of Patients With Major Depressive Disorder. 3rd ed. Arlington, VA: American Psychiatric Association;2010. 20. Ursano RJ, Bell C, Eth S, Friedman M, Norwood A, Pfefferbaum B, et al. Practice guideline for the treatment of patients with acute stress disorder and posttraumatic stress disorder. Am J Psychiatry. 2004;161(11 Suppl):3-31. 21. AngermannCE, GelbrichG, Störk S, GunoldH, Edelmann F,Wachter R, et al. Effect of escitalopram on all-cause mortality and hospitalization in patients with heart failure and depression: theMOOD-HF randomized clinical trial. JAMA. 2016;315(24):2683-93. 22. O’Connor CM, Jiang W, Kuchibhatla M, Silva SG, Cuffe MS, Callwood DD, et al. Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial. J Am Coll Cardiol. 2010;56(9):692-9. 23. Bocchi EA, Cruz F, Guimaraes G, Pinho Moreira LF, Issa VS, Ayub Ferreira SM, et al. Long-term prospective, randomized, controlled study using repetitive education at six-month intervals and monitoring for adherence in heart failure outpatients: the REMADHE trial. Circ Heart Fail. 2008;1(2):115-24. 24. Cruz FdD, Issa VS, Ayub-Ferreira SM, Chizzola PR, Souza GEC, Moreira LFP, et al. Effect of a sequential education and monitoring programme on quality-of-life components in heart failure. Eur J Heart Fail. 2010;12(9):1009-15. Referências Este é um artigo de acesso aberto distribuído sob os termos da licença de atribuição pelo Creative Commons Em conclusão, o presente artigo de Figueiredo et al., 6 reforça a importância de uma abordagem holística para pacientes com IC ao demonstrar que fatores negligenciados como transtornos de ansiedade são muito prevalentes nessa população e podem impactar a qualidade de vida. O campo do tratamento dos transtornos do humor foi pouco explorado e merece maior atenção em futuros estudos randomizados. 34